Please try another search
For the nine months ended 28 February 2022, Pharmarise Holdings Corp revenues increased less than 1% to Y38.58B. Net income applicable to common stockholders increased from Y114M to Y322M. Revenues reflect Dispensing Pharmacy Business segment increase of 1% to Y31.44B, Other segment increase of 16% to Y534M, Medical File Management segment increase of 9% to Y516M, also reflect Goods Sales Business segment decrease of 4% to Y5.71B.
Period Ending: | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 |
---|---|---|---|---|
Total Revenue | 13726 | 13477 | 13471 | 13300 |
Gross Profit | 2184 | 2141 | 2130 | 2121 |
Operating Income | 152 | 380 | 331 | 542 |
Net Income | -96 | 150 | 123 | 125 |
Period Ending: | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 |
---|---|---|---|---|
Total Assets | 26425 | 22966 | 23553 | 23421 |
Total Liabilities | 18472 | 14576 | 16572 | 16436 |
Total Equity | 7953 | 8390 | 6981 | 6985 |
Period Ending: | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 930 | 483.5 | ||
Cash From Investing Activities | -271.5 | -127.5 | ||
Cash From Financing Activities | -564 | -140 | ||
Net Change in Cash | 94 | 215.5 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review